nodes	percent_of_prediction	percent_of_DWPC	metapath
Ibandronate—Fatigue—Vemurafenib—melanoma	0.00281	0.00281	CcSEcCtD
Ibandronate—Haemoglobin—Bleomycin—melanoma	0.00279	0.00279	CcSEcCtD
Ibandronate—Constipation—Vemurafenib—melanoma	0.00279	0.00279	CcSEcCtD
Ibandronate—Haemorrhage—Bleomycin—melanoma	0.00278	0.00278	CcSEcCtD
Ibandronate—Pulmonary oedema—Docetaxel—melanoma	0.00276	0.00276	CcSEcCtD
Ibandronate—Upper respiratory tract infection—Temozolomide—melanoma	0.00272	0.00272	CcSEcCtD
Ibandronate—Pneumonia—Carmustine—melanoma	0.00272	0.00272	CcSEcCtD
Ibandronate—Depression—Carmustine—melanoma	0.00269	0.00269	CcSEcCtD
Ibandronate—Renal failure—Carmustine—melanoma	0.00265	0.00266	CcSEcCtD
Ibandronate—Weight decreased—Temozolomide—melanoma	0.00265	0.00265	CcSEcCtD
Ibandronate—Stomatitis—Carmustine—melanoma	0.00263	0.00263	CcSEcCtD
Ibandronate—Urinary tract infection—Carmustine—melanoma	0.00263	0.00263	CcSEcCtD
Ibandronate—Pneumonia—Temozolomide—melanoma	0.00262	0.00263	CcSEcCtD
Ibandronate—Infestation—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Ibandronate—Infestation NOS—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Ibandronate—Depression—Temozolomide—melanoma	0.0026	0.0026	CcSEcCtD
Ibandronate—Body temperature increased—Vemurafenib—melanoma	0.00257	0.00258	CcSEcCtD
Ibandronate—Pharyngitis—Dactinomycin—melanoma	0.00257	0.00257	CcSEcCtD
Ibandronate—Swelling—Docetaxel—melanoma	0.00255	0.00255	CcSEcCtD
Ibandronate—Stomatitis—Temozolomide—melanoma	0.00254	0.00254	CcSEcCtD
Ibandronate—Urinary tract infection—Temozolomide—melanoma	0.00254	0.00254	CcSEcCtD
Ibandronate—Deafness—Docetaxel—melanoma	0.00252	0.00252	CcSEcCtD
Ibandronate—Chills—Bleomycin—melanoma	0.00249	0.00249	CcSEcCtD
Ibandronate—Hepatobiliary disease—Temozolomide—melanoma	0.00247	0.00247	CcSEcCtD
Ibandronate—Alopecia—Bleomycin—melanoma	0.00245	0.00245	CcSEcCtD
Ibandronate—Haemoglobin—Carmustine—melanoma	0.00244	0.00244	CcSEcCtD
Ibandronate—Haemorrhage—Carmustine—melanoma	0.00242	0.00242	CcSEcCtD
Ibandronate—Erythema—Bleomycin—melanoma	0.00242	0.00242	CcSEcCtD
Ibandronate—Hypersensitivity—Vemurafenib—melanoma	0.0024	0.0024	CcSEcCtD
Ibandronate—Oedema peripheral—Carmustine—melanoma	0.00239	0.00239	CcSEcCtD
Ibandronate—Connective tissue disorder—Carmustine—melanoma	0.00238	0.00238	CcSEcCtD
Ibandronate—Renal impairment—Docetaxel—melanoma	0.00237	0.00237	CcSEcCtD
Ibandronate—Haemoglobin—Temozolomide—melanoma	0.00235	0.00236	CcSEcCtD
Ibandronate—Haemorrhage—Temozolomide—melanoma	0.00234	0.00234	CcSEcCtD
Ibandronate—Asthenia—Vemurafenib—melanoma	0.00234	0.00234	CcSEcCtD
Ibandronate—Pharyngitis—Temozolomide—melanoma	0.00233	0.00233	CcSEcCtD
Ibandronate—Chills—Dactinomycin—melanoma	0.00232	0.00232	CcSEcCtD
Ibandronate—Urinary tract disorder—Temozolomide—melanoma	0.00231	0.00231	CcSEcCtD
Ibandronate—Oedema peripheral—Temozolomide—melanoma	0.00231	0.00231	CcSEcCtD
Ibandronate—Pruritus—Vemurafenib—melanoma	0.0023	0.0023	CcSEcCtD
Ibandronate—Connective tissue disorder—Temozolomide—melanoma	0.0023	0.0023	CcSEcCtD
Ibandronate—Urethral disorder—Temozolomide—melanoma	0.0023	0.0023	CcSEcCtD
Ibandronate—Alopecia—Dactinomycin—melanoma	0.00229	0.00229	CcSEcCtD
Ibandronate—Eye disorder—Carmustine—melanoma	0.00227	0.00227	CcSEcCtD
Ibandronate—Erythema—Dactinomycin—melanoma	0.00225	0.00226	CcSEcCtD
Ibandronate—Pain in extremity—Docetaxel—melanoma	0.00225	0.00225	CcSEcCtD
Ibandronate—Ill-defined disorder—Bleomycin—melanoma	0.00224	0.00224	CcSEcCtD
Ibandronate—Anaemia—Bleomycin—melanoma	0.00223	0.00224	CcSEcCtD
Ibandronate—Diarrhoea—Vemurafenib—melanoma	0.00223	0.00223	CcSEcCtD
Ibandronate—Migraine—Docetaxel—melanoma	0.00222	0.00222	CcSEcCtD
Ibandronate—Eye disorder—Temozolomide—melanoma	0.00219	0.00219	CcSEcCtD
Ibandronate—Malaise—Bleomycin—melanoma	0.00218	0.00218	CcSEcCtD
Ibandronate—Cardiac disorder—Temozolomide—melanoma	0.00217	0.00217	CcSEcCtD
Ibandronate—Dizziness—Vemurafenib—melanoma	0.00215	0.00215	CcSEcCtD
Ibandronate—Alopecia—Carmustine—melanoma	0.00214	0.00214	CcSEcCtD
Ibandronate—Angiopathy—Temozolomide—melanoma	0.00213	0.00213	CcSEcCtD
Ibandronate—Mental disorder—Carmustine—melanoma	0.00212	0.00212	CcSEcCtD
Ibandronate—Immune system disorder—Temozolomide—melanoma	0.00212	0.00212	CcSEcCtD
Ibandronate—Mediastinal disorder—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Ibandronate—Malnutrition—Carmustine—melanoma	0.00211	0.00211	CcSEcCtD
Ibandronate—Erythema—Carmustine—melanoma	0.00211	0.00211	CcSEcCtD
Ibandronate—Chills—Temozolomide—melanoma	0.0021	0.0021	CcSEcCtD
Ibandronate—Ill-defined disorder—Dactinomycin—melanoma	0.00209	0.00209	CcSEcCtD
Ibandronate—Anaemia—Dactinomycin—melanoma	0.00208	0.00208	CcSEcCtD
Ibandronate—Vomiting—Vemurafenib—melanoma	0.00207	0.00207	CcSEcCtD
Ibandronate—Alopecia—Temozolomide—melanoma	0.00207	0.00207	CcSEcCtD
Ibandronate—Chest pain—Bleomycin—melanoma	0.00206	0.00206	CcSEcCtD
Ibandronate—Myalgia—Bleomycin—melanoma	0.00206	0.00206	CcSEcCtD
Ibandronate—Abdominal pain upper—Docetaxel—melanoma	0.00206	0.00206	CcSEcCtD
Ibandronate—Rash—Vemurafenib—melanoma	0.00205	0.00205	CcSEcCtD
Ibandronate—Mental disorder—Temozolomide—melanoma	0.00205	0.00205	CcSEcCtD
Ibandronate—Dermatitis—Vemurafenib—melanoma	0.00205	0.00205	CcSEcCtD
Ibandronate—Back pain—Carmustine—melanoma	0.00204	0.00204	CcSEcCtD
Ibandronate—Headache—Vemurafenib—melanoma	0.00204	0.00204	CcSEcCtD
Ibandronate—Erythema—Temozolomide—melanoma	0.00204	0.00204	CcSEcCtD
Ibandronate—Malnutrition—Temozolomide—melanoma	0.00204	0.00204	CcSEcCtD
Ibandronate—Breast disorder—Docetaxel—melanoma	0.00204	0.00204	CcSEcCtD
Ibandronate—Discomfort—Bleomycin—melanoma	0.00203	0.00203	CcSEcCtD
Ibandronate—Malaise—Dactinomycin—melanoma	0.00203	0.00203	CcSEcCtD
Ibandronate—Cramp muscle—Docetaxel—melanoma	0.00203	0.00203	CcSEcCtD
Ibandronate—Nasopharyngitis—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Ibandronate—Dysgeusia—Temozolomide—melanoma	0.002	0.002	CcSEcCtD
Ibandronate—Anaphylactic shock—Bleomycin—melanoma	0.00197	0.00197	CcSEcCtD
Ibandronate—Back pain—Temozolomide—melanoma	0.00197	0.00197	CcSEcCtD
Ibandronate—Infection—Bleomycin—melanoma	0.00196	0.00196	CcSEcCtD
Ibandronate—Anaemia—Carmustine—melanoma	0.00195	0.00195	CcSEcCtD
Ibandronate—Dysphagia—Docetaxel—melanoma	0.00195	0.00195	CcSEcCtD
Ibandronate—Nausea—Vemurafenib—melanoma	0.00193	0.00193	CcSEcCtD
Ibandronate—Myalgia—Dactinomycin—melanoma	0.00192	0.00192	CcSEcCtD
Ibandronate—Bronchospasm—Docetaxel—melanoma	0.00191	0.00192	CcSEcCtD
Ibandronate—Discomfort—Dactinomycin—melanoma	0.0019	0.0019	CcSEcCtD
Ibandronate—Ill-defined disorder—Temozolomide—melanoma	0.00189	0.00189	CcSEcCtD
Ibandronate—Anaemia—Temozolomide—melanoma	0.00189	0.00189	CcSEcCtD
Ibandronate—Angioedema—Temozolomide—melanoma	0.00186	0.00186	CcSEcCtD
Ibandronate—Malaise—Temozolomide—melanoma	0.00184	0.00184	CcSEcCtD
Ibandronate—Vertigo—Temozolomide—melanoma	0.00183	0.00183	CcSEcCtD
Ibandronate—Infection—Dactinomycin—melanoma	0.00183	0.00183	CcSEcCtD
Ibandronate—Hypertension—Carmustine—melanoma	0.00182	0.00182	CcSEcCtD
Ibandronate—Palpitations—Temozolomide—melanoma	0.0018	0.0018	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Bleomycin—melanoma	0.0018	0.0018	CcSEcCtD
Ibandronate—Chest pain—Carmustine—melanoma	0.0018	0.0018	CcSEcCtD
Ibandronate—Myalgia—Carmustine—melanoma	0.0018	0.0018	CcSEcCtD
Ibandronate—Anxiety—Carmustine—melanoma	0.00179	0.00179	CcSEcCtD
Ibandronate—Paraesthesia—Bleomycin—melanoma	0.00177	0.00177	CcSEcCtD
Ibandronate—Weight decreased—Docetaxel—melanoma	0.00176	0.00176	CcSEcCtD
Ibandronate—Hypertension—Temozolomide—melanoma	0.00176	0.00176	CcSEcCtD
Ibandronate—Pneumonia—Docetaxel—melanoma	0.00175	0.00175	CcSEcCtD
Ibandronate—Myalgia—Temozolomide—melanoma	0.00174	0.00174	CcSEcCtD
Ibandronate—Arthralgia—Temozolomide—melanoma	0.00174	0.00174	CcSEcCtD
Ibandronate—Infestation NOS—Docetaxel—melanoma	0.00174	0.00174	CcSEcCtD
Ibandronate—Infestation—Docetaxel—melanoma	0.00174	0.00174	CcSEcCtD
Ibandronate—Anxiety—Temozolomide—melanoma	0.00173	0.00173	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00172	0.00172	CcSEcCtD
Ibandronate—Discomfort—Temozolomide—melanoma	0.00172	0.00172	CcSEcCtD
Ibandronate—Decreased appetite—Bleomycin—melanoma	0.00172	0.00172	CcSEcCtD
Ibandronate—Infection—Carmustine—melanoma	0.00171	0.00171	CcSEcCtD
Ibandronate—Renal failure—Docetaxel—melanoma	0.00171	0.00171	CcSEcCtD
Ibandronate—Dry mouth—Temozolomide—melanoma	0.0017	0.0017	CcSEcCtD
Ibandronate—Stomatitis—Docetaxel—melanoma	0.00169	0.00169	CcSEcCtD
Ibandronate—Pain—Bleomycin—melanoma	0.00169	0.00169	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Dactinomycin—melanoma	0.00168	0.00168	CcSEcCtD
Ibandronate—Anaphylactic shock—Temozolomide—melanoma	0.00166	0.00166	CcSEcCtD
Ibandronate—Infection—Temozolomide—melanoma	0.00165	0.00165	CcSEcCtD
Ibandronate—Hepatobiliary disease—Docetaxel—melanoma	0.00164	0.00164	CcSEcCtD
Ibandronate—Nervous system disorder—Temozolomide—melanoma	0.00163	0.00163	CcSEcCtD
Ibandronate—Feeling abnormal—Bleomycin—melanoma	0.00163	0.00163	CcSEcCtD
Ibandronate—Skin disorder—Temozolomide—melanoma	0.00162	0.00162	CcSEcCtD
Ibandronate—Hyperhidrosis—Temozolomide—melanoma	0.00161	0.00161	CcSEcCtD
Ibandronate—Decreased appetite—Dactinomycin—melanoma	0.0016	0.0016	CcSEcCtD
Ibandronate—Fatigue—Dactinomycin—melanoma	0.00159	0.00159	CcSEcCtD
Ibandronate—Pain—Dactinomycin—melanoma	0.00157	0.00157	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Carmustine—melanoma	0.00157	0.00157	CcSEcCtD
Ibandronate—Urticaria—Bleomycin—melanoma	0.00157	0.00157	CcSEcCtD
Ibandronate—Haemoglobin—Docetaxel—melanoma	0.00157	0.00157	CcSEcCtD
Ibandronate—Body temperature increased—Bleomycin—melanoma	0.00156	0.00156	CcSEcCtD
Ibandronate—Haemorrhage—Docetaxel—melanoma	0.00156	0.00156	CcSEcCtD
Ibandronate—Insomnia—Carmustine—melanoma	0.00156	0.00156	CcSEcCtD
Ibandronate—Paraesthesia—Carmustine—melanoma	0.00155	0.00155	CcSEcCtD
Ibandronate—Pharyngitis—Docetaxel—melanoma	0.00155	0.00155	CcSEcCtD
Ibandronate—Urinary tract disorder—Docetaxel—melanoma	0.00154	0.00154	CcSEcCtD
Ibandronate—Oedema peripheral—Docetaxel—melanoma	0.00153	0.00154	CcSEcCtD
Ibandronate—Connective tissue disorder—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Ibandronate—Urethral disorder—Docetaxel—melanoma	0.00153	0.00153	CcSEcCtD
Ibandronate—Feeling abnormal—Dactinomycin—melanoma	0.00152	0.00152	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Temozolomide—melanoma	0.00152	0.00152	CcSEcCtD
Ibandronate—Insomnia—Temozolomide—melanoma	0.00151	0.00151	CcSEcCtD
Ibandronate—Gastrointestinal pain—Dactinomycin—melanoma	0.0015	0.00151	CcSEcCtD
Ibandronate—Decreased appetite—Carmustine—melanoma	0.0015	0.0015	CcSEcCtD
Ibandronate—Paraesthesia—Temozolomide—melanoma	0.00149	0.00149	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Carmustine—melanoma	0.00149	0.00149	CcSEcCtD
Ibandronate—Pain—Carmustine—melanoma	0.00147	0.00147	CcSEcCtD
Ibandronate—Constipation—Carmustine—melanoma	0.00147	0.00147	CcSEcCtD
Ibandronate—Dyspepsia—Temozolomide—melanoma	0.00147	0.00147	CcSEcCtD
Ibandronate—Eye disorder—Docetaxel—melanoma	0.00146	0.00146	CcSEcCtD
Ibandronate—Body temperature increased—Dactinomycin—melanoma	0.00145	0.00146	CcSEcCtD
Ibandronate—Abdominal pain—Dactinomycin—melanoma	0.00145	0.00146	CcSEcCtD
Ibandronate—Hypersensitivity—Bleomycin—melanoma	0.00145	0.00145	CcSEcCtD
Ibandronate—Decreased appetite—Temozolomide—melanoma	0.00145	0.00145	CcSEcCtD
Ibandronate—Cardiac disorder—Docetaxel—melanoma	0.00145	0.00145	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Temozolomide—melanoma	0.00144	0.00144	CcSEcCtD
Ibandronate—Fatigue—Temozolomide—melanoma	0.00144	0.00144	CcSEcCtD
Ibandronate—Pain—Temozolomide—melanoma	0.00142	0.00142	CcSEcCtD
Ibandronate—Constipation—Temozolomide—melanoma	0.00142	0.00142	CcSEcCtD
Ibandronate—Feeling abnormal—Carmustine—melanoma	0.00142	0.00142	CcSEcCtD
Ibandronate—Asthenia—Bleomycin—melanoma	0.00142	0.00142	CcSEcCtD
Ibandronate—Angiopathy—Docetaxel—melanoma	0.00141	0.00141	CcSEcCtD
Ibandronate—Gastrointestinal pain—Carmustine—melanoma	0.00141	0.00141	CcSEcCtD
Ibandronate—Immune system disorder—Docetaxel—melanoma	0.00141	0.00141	CcSEcCtD
Ibandronate—Mediastinal disorder—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Ibandronate—Chills—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Ibandronate—Pruritus—Bleomycin—melanoma	0.0014	0.0014	CcSEcCtD
Ibandronate—Alopecia—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Ibandronate—Feeling abnormal—Temozolomide—melanoma	0.00137	0.00137	CcSEcCtD
Ibandronate—Mental disorder—Docetaxel—melanoma	0.00136	0.00137	CcSEcCtD
Ibandronate—Abdominal pain—Carmustine—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Body temperature increased—Carmustine—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Gastrointestinal pain—Temozolomide—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Erythema—Docetaxel—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Malnutrition—Docetaxel—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Hypersensitivity—Dactinomycin—melanoma	0.00136	0.00136	CcSEcCtD
Ibandronate—Dysgeusia—Docetaxel—melanoma	0.00133	0.00133	CcSEcCtD
Ibandronate—Urticaria—Temozolomide—melanoma	0.00132	0.00132	CcSEcCtD
Ibandronate—Asthenia—Dactinomycin—melanoma	0.00132	0.00132	CcSEcCtD
Ibandronate—Abdominal pain—Temozolomide—melanoma	0.00132	0.00132	CcSEcCtD
Ibandronate—Body temperature increased—Temozolomide—melanoma	0.00132	0.00132	CcSEcCtD
Ibandronate—Back pain—Docetaxel—melanoma	0.00131	0.00131	CcSEcCtD
Ibandronate—Muscle spasms—Docetaxel—melanoma	0.0013	0.0013	CcSEcCtD
Ibandronate—Hypersensitivity—Carmustine—melanoma	0.00127	0.00127	CcSEcCtD
Ibandronate—Diarrhoea—Dactinomycin—melanoma	0.00126	0.00126	CcSEcCtD
Ibandronate—Vomiting—Bleomycin—melanoma	0.00125	0.00125	CcSEcCtD
Ibandronate—Anaemia—Docetaxel—melanoma	0.00125	0.00125	CcSEcCtD
Ibandronate—Rash—Bleomycin—melanoma	0.00124	0.00124	CcSEcCtD
Ibandronate—Dermatitis—Bleomycin—melanoma	0.00124	0.00124	CcSEcCtD
Ibandronate—Asthenia—Carmustine—melanoma	0.00124	0.00124	CcSEcCtD
Ibandronate—Hypersensitivity—Temozolomide—melanoma	0.00123	0.00123	CcSEcCtD
Ibandronate—Palpitations—Docetaxel—melanoma	0.0012	0.0012	CcSEcCtD
Ibandronate—Asthenia—Temozolomide—melanoma	0.00119	0.00119	CcSEcCtD
Ibandronate—Diarrhoea—Carmustine—melanoma	0.00118	0.00118	CcSEcCtD
Ibandronate—Pruritus—Temozolomide—melanoma	0.00118	0.00118	CcSEcCtD
Ibandronate—Nausea—Bleomycin—melanoma	0.00117	0.00117	CcSEcCtD
Ibandronate—Hypertension—Docetaxel—melanoma	0.00117	0.00117	CcSEcCtD
Ibandronate—Vomiting—Dactinomycin—melanoma	0.00117	0.00117	CcSEcCtD
Ibandronate—Rash—Dactinomycin—melanoma	0.00116	0.00116	CcSEcCtD
Ibandronate—Myalgia—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Ibandronate—Chest pain—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Ibandronate—Arthralgia—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Ibandronate—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Ibandronate—Dizziness—Carmustine—melanoma	0.00114	0.00114	CcSEcCtD
Ibandronate—Diarrhoea—Temozolomide—melanoma	0.00114	0.00114	CcSEcCtD
Ibandronate—Dry mouth—Docetaxel—melanoma	0.00113	0.00113	CcSEcCtD
Ibandronate—Anaphylactic shock—Docetaxel—melanoma	0.00111	0.00111	CcSEcCtD
Ibandronate—Dizziness—Temozolomide—melanoma	0.0011	0.0011	CcSEcCtD
Ibandronate—Infection—Docetaxel—melanoma	0.0011	0.0011	CcSEcCtD
Ibandronate—Vomiting—Carmustine—melanoma	0.0011	0.0011	CcSEcCtD
Ibandronate—Nausea—Dactinomycin—melanoma	0.00109	0.00109	CcSEcCtD
Ibandronate—Shock—Docetaxel—melanoma	0.00109	0.00109	CcSEcCtD
Ibandronate—Rash—Carmustine—melanoma	0.00109	0.00109	CcSEcCtD
Ibandronate—Nervous system disorder—Docetaxel—melanoma	0.00109	0.00109	CcSEcCtD
Ibandronate—Dermatitis—Carmustine—melanoma	0.00109	0.00109	CcSEcCtD
Ibandronate—Headache—Carmustine—melanoma	0.00108	0.00108	CcSEcCtD
Ibandronate—Skin disorder—Docetaxel—melanoma	0.00108	0.00108	CcSEcCtD
Ibandronate—Vomiting—Temozolomide—melanoma	0.00106	0.00106	CcSEcCtD
Ibandronate—Rash—Temozolomide—melanoma	0.00105	0.00105	CcSEcCtD
Ibandronate—Dermatitis—Temozolomide—melanoma	0.00105	0.00105	CcSEcCtD
Ibandronate—Headache—Temozolomide—melanoma	0.00104	0.00104	CcSEcCtD
Ibandronate—Nausea—Carmustine—melanoma	0.00102	0.00102	CcSEcCtD
Ibandronate—Musculoskeletal discomfort—Docetaxel—melanoma	0.00101	0.00101	CcSEcCtD
Ibandronate—Insomnia—Docetaxel—melanoma	0.001	0.001	CcSEcCtD
Ibandronate—Paraesthesia—Docetaxel—melanoma	0.000994	0.000994	CcSEcCtD
Ibandronate—Nausea—Temozolomide—melanoma	0.000989	0.000989	CcSEcCtD
Ibandronate—Dyspepsia—Docetaxel—melanoma	0.000974	0.000975	CcSEcCtD
Ibandronate—Decreased appetite—Docetaxel—melanoma	0.000962	0.000962	CcSEcCtD
Ibandronate—Gastrointestinal disorder—Docetaxel—melanoma	0.000956	0.000956	CcSEcCtD
Ibandronate—Fatigue—Docetaxel—melanoma	0.000954	0.000955	CcSEcCtD
Ibandronate—Pain—Docetaxel—melanoma	0.000947	0.000947	CcSEcCtD
Ibandronate—Constipation—Docetaxel—melanoma	0.000947	0.000947	CcSEcCtD
Ibandronate—Feeling abnormal—Docetaxel—melanoma	0.000912	0.000912	CcSEcCtD
Ibandronate—Gastrointestinal pain—Docetaxel—melanoma	0.000905	0.000905	CcSEcCtD
Ibandronate—Abdominal pain—Docetaxel—melanoma	0.000875	0.000875	CcSEcCtD
Ibandronate—Body temperature increased—Docetaxel—melanoma	0.000875	0.000875	CcSEcCtD
Ibandronate—Hypersensitivity—Docetaxel—melanoma	0.000816	0.000816	CcSEcCtD
Ibandronate—Asthenia—Docetaxel—melanoma	0.000794	0.000794	CcSEcCtD
Ibandronate—Pruritus—Docetaxel—melanoma	0.000783	0.000783	CcSEcCtD
Ibandronate—Diarrhoea—Docetaxel—melanoma	0.000757	0.000757	CcSEcCtD
Ibandronate—Dizziness—Docetaxel—melanoma	0.000732	0.000732	CcSEcCtD
Ibandronate—Vomiting—Docetaxel—melanoma	0.000704	0.000704	CcSEcCtD
Ibandronate—Rash—Docetaxel—melanoma	0.000698	0.000698	CcSEcCtD
Ibandronate—Dermatitis—Docetaxel—melanoma	0.000697	0.000697	CcSEcCtD
Ibandronate—Headache—Docetaxel—melanoma	0.000693	0.000694	CcSEcCtD
Ibandronate—Nausea—Docetaxel—melanoma	0.000657	0.000658	CcSEcCtD
Ibandronate—Risedronate—PTGS2—melanoma	0.000179	1	CrCbGaD
